Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer.
Gynecol Oncol. 2017 Sep;146(3):449-456. doi: 10.1016/j.ygyno.2017.06.019. Epub 2017 Jun 20.
Gynecol Oncol. 2017.
PMID: 28645428
Clinical Trial.
Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.
Rutten MJ, van Meurs HS, van de Vrie R, Gaarenstroom KN, Naaktgeboren CA, van Gorp T, Ter Brugge HG, Hofhuis W, Schreuder HW, Arts HJ, Zusterzeel PL, Pijnenborg JM, van Haaften M, Fons G, Engelen MJ, Boss EA, Vos MC, Gerestein KG, Schutter EM, Opmeer BC, Spijkerboer AM, Bossuyt PM, Mol BW, Kenter GG, Buist MR.
Rutten MJ, et al. Among authors: van de vrie r.
J Clin Oncol. 2017 Feb 20;35(6):613-621. doi: 10.1200/JCO.2016.69.2962. Epub 2016 Dec 28.
J Clin Oncol. 2017.
PMID: 28029317
Clinical Trial.
Item in Clipboard
Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer.
van de Vrie R, Rutten MJ, Asseler JD, Leeflang MM, Kenter GG, Mol BWJ, Buist M.
van de Vrie R, et al.
Cochrane Database Syst Rev. 2019 Mar 23;3(3):CD009786. doi: 10.1002/14651858.CD009786.pub3.
Cochrane Database Syst Rev. 2019.
PMID: 30907434
Free PMC article.
Item in Clipboard
Predicting surgical outcome in patients with International Federation of Gynecology and Obstetrics stage III or IV ovarian cancer using computed tomography: a systematic review of prediction models.
Rutten MJ, van de Vrie R, Bruining A, Spijkerboer AM, Mol BW, Kenter GG, Buist MR.
Rutten MJ, et al. Among authors: van de vrie r.
Int J Gynecol Cancer. 2015 Mar;25(3):407-15. doi: 10.1097/IGC.0000000000000368.
Int J Gynecol Cancer. 2015.
PMID: 25695545
Review.
Item in Clipboard
The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy.
Tajik P, van de Vrie R, Zafarmand MH, Coens C, Buist MR, Vergote I, Bossuyt PMM, Kenter GG.
Tajik P, et al. Among authors: van de vrie r.
Int J Gynecol Cancer. 2018 Mar;28(3):453-458. doi: 10.1097/IGC.0000000000001186.
Int J Gynecol Cancer. 2018.
PMID: 29324537
Item in Clipboard
Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4.
Lof P, van de Vrie R, Korse CM, van Driel WJ, van Gent MDJM, Karlsen MA, Amant F, Lok CAR.
Lof P, et al. Among authors: van de vrie r.
Int J Gynecol Cancer. 2019 Oct;29(8):1304-1310. doi: 10.1136/ijgc-2019-000581. Epub 2019 Sep 11.
Int J Gynecol Cancer. 2019.
PMID: 31515411
Item in Clipboard
Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?
Lof P, van de Vrie R, Korse CM, van Gent MDJM, Mom CH, Rosier-van Dunné FMF, van Baal WM, Verhoeve HR, Hermsen BBJ, Verbruggen MB, Hemelaar M, van de Swaluw AMG, Knipscheer HC, Huirne JAF, Westenberg SM, van der Noort V, Amant F, van den Broek D, Lok CAR.
Lof P, et al. Among authors: van de vrie r.
Gynecol Oncol. 2022 Aug;166(2):284-291. doi: 10.1016/j.ygyno.2022.05.025. Epub 2022 Jun 8.
Gynecol Oncol. 2022.
PMID: 35688656
Item in Clipboard
Cite
Cite